{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:50:41Z","timestamp":1790419841057,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vaccine.2022.08.059","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T23:56:54Z","timestamp":1662163014000},"page":"5769-5780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Enhancement of live vaccines by co-delivery of immune modulating proteins"],"prefix":"10.1016","volume":"40","author":[{"given":"Megha M.","family":"Manohar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Walduck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.08.059_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1475-2859-5-23","article-title":"Live bacterial vaccines \u2013 a review and identification of potential hazards","volume":"5","author":"Detmer","year":"2006","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.vaccine.2022.08.059_b0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/vaccines7040150","article-title":"Adjuvant strategies for lactic acid bacterial mucosal vaccines","volume":"7","author":"Vilander","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2022.08.059_b0015","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0264-410X(02)00579-0","article-title":"Experience with registered mucosal vaccines","volume":"21","author":"Dietrich","year":"2003","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2022.08.059_b0020","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.4049\/jimmunol.175.11.7297","article-title":"A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors","volume":"175","author":"Berm\u00fadez-Humar\u00e1n","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0025","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1473-3099(08)70231-7","article-title":"Rotavirus vaccines: viral shedding and risk of transmission","volume":"8","author":"Anderson","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.059_b0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4110\/in.2019.19.e38","article-title":"Human immunity against Campylobacter infection","volume":"19","author":"Hameed","year":"2019","journal-title":"Immune Netw"},{"key":"10.1016\/j.vaccine.2022.08.059_b0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/mi.2011.2","article-title":"Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda","volume":"4","author":"Griffin","year":"2011","journal-title":"Mucosal Immunol"},{"issue":"10002","key":"10.1016\/j.vaccine.2022.08.059_b0040","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","article-title":"Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"Zeng","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.08.059_b0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/CMR.00005-07","article-title":"Current status of veterinary vaccines","volume":"20","author":"Meeusen","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2022.08.059_b0050","doi-asserted-by":"crossref","unstructured":"Aida V, Pliasas VC, Neasham PJ, North JF, McWhorter KL, Glover SR, et al. Novel vaccine technologies in veterinary medicine: a herald to human medicine vaccines. Front. Vet. Sci 2021;8;654289. doi: 10.3389\/fvets.2021.654289.","DOI":"10.3389\/fvets.2021.654289"},{"key":"10.1016\/j.vaccine.2022.08.059_b0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biori.2017.10.001","article-title":"The development of veterinary vaccines: a review of traditional methods and modern biotechnology approaches","volume":"1","author":"Jorge","year":"2017","journal-title":"BIORI"},{"key":"10.1016\/j.vaccine.2022.08.059_b0060","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.vaccine.2021.11.034","article-title":"Non-specific effects of veterinary vaccines: a systematic review","volume":"40","author":"Arega","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.08.059_b0065","unstructured":"Bioproperties \u2013 Vaccines. Available from: http:\/\/www.bioproperties.com.au\/!Pages\/Vaccines\/Vaccines.html (accessed June 21, 2022)."},{"key":"10.1016\/j.vaccine.2022.08.059_b0070","unstructured":"Equilis StrepE | European Medicines Agency. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/veterinary\/EPAR\/equilis-strepe (accessed June 22, 2022)."},{"key":"10.1016\/j.vaccine.2022.08.059_b0075","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2460\/ajvr.2004.65.559","article-title":"Evaluation of protective immunity in pigs following oral administration of an avirulent live vaccine of Lawsonia intracellularis","volume":"65","author":"Kroll","year":"2004","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2022.08.059_b0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/vr.141.3.63","article-title":"Use of a live chlamydial vaccine to prevent ovine enzootic abortion","volume":"141","author":"Chalmers","year":"1997","journal-title":"Vet Rec"},{"issue":"3-4","key":"10.1016\/j.vaccine.2022.08.059_b0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vetimm.2004.05.002","article-title":"Salmonella enteritidisclearance and immune responses in chickens following Salmonella vaccination and challenge","volume":"101","author":"Babu","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0090","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2307\/1590467","article-title":"Efficacy of a commercial turkey coryza vaccine (Art-Vax) in turkey poults","volume":"29","author":"Jackwood","year":"1985","journal-title":"Avian Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2022.08.059_b0095","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/nm1210","article-title":"Targeting the innate immune response with improved vaccine adjuvants","volume":"10","author":"Pashine","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2022.08.059_b0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/0974-777X.77299","article-title":"Fundamentals of vaccine immunology","volume":"3","author":"Clem","year":"2011","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.059_b0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fimmu.2014.00188","article-title":"Role of fused Mycobacterium tuberculosis immunogens and adjuvants in modern tuberculosis vaccines","volume":"5","author":"Junqueira-Kipnis","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/femsre\/fuaa015","article-title":"The food-gut axis: lactic acid bacteria and their link to food, the gut microbiome and human health","volume":"44","author":"De Filippis","year":"2020","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.059_b0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12934-018-0861-7","article-title":"Oral recombinant Lactobacillus vaccine targeting the intestinal microfold cells and dendritic cells for delivering the core neutralizing epitope of porcine epidemic diarrhea virus","volume":"17","author":"Ma","year":"2018","journal-title":"Microb Cell Factories"},{"issue":"4","key":"10.1016\/j.vaccine.2022.08.059_b0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/86373","article-title":"Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria","volume":"2","author":"Rescigno","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/taap.1997.8126","article-title":"Induction of liver-associated transforming growth factor \u03b21 (TGF-\u03b21) mrna expression by carbon tetrachloride leads to the inhibition of T helper 2 cell-associated lymphokines","volume":"144","author":"Jeon","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.189.3.541","article-title":"Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression","volume":"189","author":"Braun","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2022.08.059_b0135","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1574-6968.2007.01038.x","article-title":"Production of biological active murine IFN-\u03b3 by recombinant Lactococcus lactis","volume":"280","author":"Berm\u00fadez-Humar\u00e1n","year":"2008","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2022.08.059_b0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1365-2249.2000.01100.x","article-title":"Bacille Calmette-Gu\u00e9rin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-\u03b3)","volume":"119","author":"Wangoo","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"6082","key":"10.1016\/j.vaccine.2022.08.059_b0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life","volume":"2","author":"Hart","year":"1977","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.059_b0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12896-018-0461-y","article-title":"Proof of concept in utilizing in-trans surface display system of Lactobacillus plantarum as mucosal tuberculosis vaccine via oral administration in mice","volume":"18","author":"Mustafa","year":"2018","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1751-0813.1990.tb07748.x","article-title":"Immunogenicity of a temperature sensitive mutant Mycoplasma gallisepticum vaccine","volume":"67","author":"Whithear","year":"1990","journal-title":"Aust Vet J"},{"issue":"43","key":"10.1016\/j.vaccine.2022.08.059_b0160","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1016\/j.vaccine.2008.07.076","article-title":"Development and immunogenicity of recombinant Mycoplasma gallisepticum vaccine strain ts-11 expressing chicken IFN-\u03b3","volume":"26","author":"Muneta","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.08.059_b0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00430-012-0248-z","article-title":"IFN\u03b3 expression by an attenuated strain of Salmonella enterica serovar Typhimurium improves vaccine efficacy in susceptible TLR4-defective C3H\/HeJ mice","volume":"202","author":"Al-Ojali","year":"2013","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0170","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1745-7270.2006.00217.x","article-title":"Immunological properties of recombinant Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin strain expressing fusion protein IL-2-ESAT-6","volume":"38","author":"Fan","year":"2006","journal-title":"Acta Biochim Biophys Sinica"},{"key":"10.1016\/j.vaccine.2022.08.059_b0175","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1348-0421.2011.00376.x","article-title":"Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein","volume":"55","author":"Deng","year":"2011","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0180","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/586902","article-title":"Efficacy of recombinant Bacille Calmette-Gu\u00e9rin vaccine decreting interleukin-15\/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis","volume":"197","author":"Tang","year":"2008","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2022.08.059_b0185","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1128\/IAI.66.7.3183-3189.1998","article-title":"Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine","volume":"66","author":"Steidler","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.08.059_b0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/CVI.00337-09","article-title":"Adjuvant effects for oral immunization provided by recombinant Lactobacillus casei secreting biologically active murine Interleukin-1\u03b2","volume":"17","author":"Kajikawa","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0195","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1348-0421.2011.00370.x","article-title":"Lactobacillus rhamnosus GG secreting an antigen and Interleukin-2 translocates across the gastrointestinal tract and induces an antigen specific immune response","volume":"55","author":"Kandasamy","year":"2011","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0200","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/j.vaccine.2007.06.062","article-title":"Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria","volume":"25","author":"Cortes-Perez","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.08.059_b0205","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1016\/j.vaccine.2012.07.004","article-title":"Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB\/c mice against Leishmania major infection","volume":"30","author":"Hugentobler","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.08.059_b0210","doi-asserted-by":"crossref","first-page":"e30945","DOI":"10.1371\/journal.pone.0030945","article-title":"Immunization against Leishmania major infection using LACK- and IL-12-expressing Lactococcus lactis induces delay in footpad swelling","volume":"7","author":"Hugentobler","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2022.08.059_b0215","doi-asserted-by":"crossref","DOI":"10.18388\/abp.2014_1884","article-title":"Expression of avian influenza haemagglutinin (H5) and chicken interleukin 2 (chIL-2) under control of the ptcB promoter in Lactococcus lactis","volume":"61","author":"Szatraj","year":"2014","journal-title":"Acta Biochim Pol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.08.059_b0220","first-page":"754","article-title":"A phase I trial with transgenic bacteria expressing Interleukin-10 in Crohn\u2019s disease","volume":"4","author":"Braat","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0225","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3389\/fimmu.2018.02691","article-title":"Delivery of IL-35 by Lactococcus lactis ameliorates collagen-induced arthritis in mice","volume":"9","author":"Maddaloni","year":"2018","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.08.059_b0230","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nbt840","article-title":"Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10","volume":"21","author":"Steidler","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0235","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.vaccine.2010.02.077","article-title":"Innate and acquired immune responses induced by recombinant Lactobacillus casei displaying flagellin-fusion antigen on the cell-surface","volume":"28","author":"Kajikawa","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.08.059_b0240","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.vaccine.2007.01.055","article-title":"Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis","volume":"25","author":"Kajikawa","year":"2007","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2022.08.059_b0245","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/CVI.05277-11","article-title":"Assessment of Lactobacillus gasseri as a candidate oral vaccine vector","volume":"18","author":"Stoeker","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0250","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1073\/pnas.0900029106","article-title":"Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge","volume":"106","author":"Mohamadzadeh","year":"2009","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.vaccine.2022.08.059_b0255","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2217\/fmb.10.78","article-title":"Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine","volume":"5","author":"Mohamadzadeh","year":"2010","journal-title":"Future Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.08.059_b0260","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/v9110312","article-title":"Oral delivery of probiotics expressing dendritic cell-targeting peptide fused with porcine epidemic diarrhea virus COE antigen: a promising vaccine strategy against PEDV","volume":"9","author":"Wang","year":"2017","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2022.08.059_b0265","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/v10030106","article-title":"Oral immunization against PEDV with recombinant Lactobacillus casei expressing dendritic cell-targeting peptide fusing COE protein of PEDV in piglets","volume":"10","author":"Hou","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2022.08.059_b0270","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virusres.2017.12.011","article-title":"Construction and immunogenicity analysis of Lactobacillus plantarum expressing a porcine epidemic diarrhea virus S gene fused to a DC-targeting peptide","volume":"247","author":"Huang","year":"2018","journal-title":"Virus Res"},{"issue":"11","key":"10.1016\/j.vaccine.2022.08.059_b0275","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1007\/s00253-017-8230-8","article-title":"Protection of chickens against H9N2 avian influenza virus challenge with recombinant Lactobacillus plantarum expressing conserved antigens","volume":"101","author":"Yang","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0280","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virusres.2015.09.005","article-title":"Lactobacillus plantarum vaccine vector expressing hemagglutinin provides protection against H9N2 challenge infection","volume":"211","author":"Shi","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2022.08.059_b0285","doi-asserted-by":"crossref","first-page":"39665","DOI":"10.1038\/srep39665","article-title":"Cross-protective efficacy of dendritic cells targeting conserved influenza virus antigen expressed by Lactobacillus plantarum","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2022.08.059_b0290","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/09540105.2020.1733495","article-title":"Recombinant Lactococcus lactis co-expressing dendritic cell target peptide and E. tenella 3\u20131E protein: immune response and efficacy against homologous challenge","volume":"31","author":"Li","year":"2020","journal-title":"Food Agric Immunol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0295","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.vetpar.2017.01.023","article-title":"Construction and immunological evaluation of recombinant Lactobacillus plantarum expressing SO7 of Eimeria tenella fusion DC-targeting peptide","volume":"236","author":"Yang","year":"2017","journal-title":"Vet Parasitol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.08.059_b0300","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/v11060575","article-title":"Dendritic cell targeting of Bovine Viral Diarrhea Virus E2 protein expressed by Lactobacillus casei effectively induces antigen-specific immune responses via oral vaccination","volume":"11","author":"Wang","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.059_b0305","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.vaccine.2017.11.008","article-title":"Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex","volume":"36","author":"Sahay","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.08.059_b0310","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3920\/BM2016.0116","article-title":"Alleviation of enterotoxigenic Escherichia coli challenge by recombinant Lactobacillus plantarum expressing a FaeG- and DC-targeting peptide fusion protein","volume":"8","author":"Yang","year":"2017","journal-title":"Benef Microbes"},{"key":"10.1016\/j.vaccine.2022.08.059_b0315","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jbiotec.2015.09.033","article-title":"Construction and immunological evaluation of recombinant Lactobacillus plantarum expressing HN of Newcastle disease virus and DC- targeting peptide fusion protein","volume":"216","author":"Jiang","year":"2015","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0320","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","article-title":"An overview of the immune system","volume":"357","author":"Parkin","year":"2001","journal-title":"Lancet; London"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.059_b0325","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12865-015-0132-x","article-title":"Soluble RANKL expression in Lactococcus lactis and investigation of its potential as an oral vaccine adjuvant","volume":"16","author":"Kim","year":"2015","journal-title":"BMC Immunol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0330","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3382\/ps.2010-00697","article-title":"Evaluation of recombinant Salmonella expressing CD154 for persistence and enhanced antibody response in commercial turkeys","volume":"89","author":"O\u2019Meara","year":"2010","journal-title":"Poult Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2022.08.059_b0335","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3382\/ps.2009-00251","article-title":"Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge","volume":"88","author":"Layton","year":"2009","journal-title":"Poult Sci"},{"key":"10.1016\/j.vaccine.2022.08.059_b0340","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13567-018-0593-z","article-title":"Salmonella Gallinarum delivering M2eCD40L in protein and DNA formats acts as a bivalent vaccine against fowl typhoid and H9N2 infection in chickens","volume":"49","author":"Hajam","year":"2018","journal-title":"Vet Res"},{"issue":"11","key":"10.1016\/j.vaccine.2022.08.059_b0345","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3923\/ijps.2010.1031.1037","article-title":"Development and evaluation of an \u0394 aroA \/ \u0394 htrA Salmonella enteritidis vector expressing Eimeria maxima TRAP family protein EmTFP250 with CD154 (CD 40L) as candidate vaccines against coccidiosis in broilers","volume":"9","author":"Shivaramai","year":"2010","journal-title":"Int J Poult Sci"},{"key":"10.1016\/j.vaccine.2022.08.059_b0350","doi-asserted-by":"crossref","first-page":"108604","DOI":"10.1016\/j.vetmic.2020.108604","article-title":"Efficacy of orally administered porcine epidemic diarrhea vaccine-loaded hydroxypropyl methylcellulose phthalate microspheres and RANKL-secreting L. lactis","volume":"242","author":"Choe","year":"2020","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0355","doi-asserted-by":"crossref","first-page":"e713769","DOI":"10.1155\/2011\/713769","article-title":"Bacterial toxin fusion proteins elicit mucosal immunity against a foot-and-mouth disease virus antigen when administered intranasally to guinea pigs","volume":"2011","author":"Challa","year":"2011","journal-title":"Adv Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.08.059_b0360","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1248\/bpb.b12-01021","article-title":"Expression and secretion of cholera toxin B subunit in Lactobacilli","volume":"36","author":"Okuno","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.vaccine.2022.08.059_b0365","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00284-005-0388-0","article-title":"Haemagglutination induced by Bordetella pertussis Filamentous Haemagglutinin Adhesin (FHA) is inhibited by antibodies produced against FHA430\u2013873 fragment expressed in Lactobacillus casei","volume":"53","author":"Colombi","year":"2006","journal-title":"Curr Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.08.059_b0370","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1128\/CVI.00050-11","article-title":"Evaluation of oral immunization with recombinant Avian Influenza Virus HA1 displayed on the Lactococcus lactis surface and combined with the mucosal adjuvant cholera toxin subunit B","volume":"18","author":"Lei","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"3-4","key":"10.1016\/j.vaccine.2022.08.059_b0375","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.vetmic.2015.07.020","article-title":"Mucosally administered Lactobacillus surface-displayed influenza antigens (sM2 and HA2) with cholera toxin subunit A1 (CTA1) induce broadly protective immune responses against divergent influenza subtypes","volume":"179","author":"Li","year":"2015","journal-title":"Vet Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.08.059_b0380","doi-asserted-by":"crossref","first-page":"e94051","DOI":"10.1371\/journal.pone.0094051","article-title":"Mucosal vaccination with recombinant Lactobacillus casei-displayed CTA1-conjugated consensus Matrix Protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB\/c mice","volume":"9","author":"Chowdhury","year":"2014","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2022.08.059_b0385","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/jam.13352","article-title":"Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice","volume":"122","author":"Yu","year":"2017","journal-title":"J App Microbiol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0390","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jbiotec.2017.08.011","article-title":"Molecular mechanisms underlying protection against H9N2 influenza virus challenge in mice by recombinant Lactobacillus plantarum with surface displayed HA2-LTB","volume":"259","author":"Jiang","year":"2017","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0395","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2180-9-249","article-title":"Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice","volume":"9","author":"Qiao","year":"2009","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0400","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/abbs\/gmr045","article-title":"A novel recombinant Mycobacterium bovis bacillus Calmette\u2212Guerin strain expressing human granulocyte macrophage colony-stimulating factor and Mycobacterium tuberculosis early secretory antigenic target 6 complex augments Th1 immunity","volume":"43","author":"Yang","year":"2011","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.vaccine.2022.08.059_b0405","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12934-015-0290-9","article-title":"Surface display of an anti-DEC-205 single chain Fv fragment in Lactobacillus plantarum increases internalization and plasmid transfer to dendritic cells in vitro and in vivo","volume":"14","author":"Christophe","year":"2015","journal-title":"Microb Cell Factories"},{"key":"10.1016\/j.vaccine.2022.08.059_b0410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2016.11.025","article-title":"Protective efficacy of Fc targeting conserved influenza virus M2e antigen expressed by Lactobacillus plantarum","volume":"138","author":"Yang","year":"2017","journal-title":"Antivir Res"},{"issue":"16","key":"10.1016\/j.vaccine.2022.08.059_b0415","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.vaccine.2015.02.061","article-title":"Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization","volume":"33","author":"Li","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.08.059_b0420","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1016\/j.vaccine.2007.04.090","article-title":"Molecular adjuvant C3d3 improved the anti-hCG\u03b2 humoral immune response in vaginal inoculation with live recombinant Lactobacillus expressing hCG\u03b2-C3d3 fusion protein","volume":"25","author":"Yao","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.08.059_b0425","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.18632\/oncotarget.14314","article-title":"N-glycosylation converts non-glycoproteins into mannose receptor ligands and reveals antigen-specific T cell responses in vivo","volume":"8","author":"Kreer","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.059_b0430","doi-asserted-by":"crossref","first-page":"26511","DOI":"10.1038\/srep26511","article-title":"Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccine","volume":"6","author":"Nothaft","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2022.08.059_b0435","doi-asserted-by":"crossref","unstructured":"Stebegg M, Kumar SD, Silva-Cayetano A, Fonseca VR, Linterman MA, Graca L. Regulation of the germinal center response. Front Immunol. 2018;9;2469. doi: 10.3389\/fimmu.2018.02469.","DOI":"10.3389\/fimmu.2018.02469"},{"issue":"12","key":"10.1016\/j.vaccine.2022.08.059_b0440","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1099\/jgv.0.000646","article-title":"Recombinant rabies virus expressing IL-21 enhances immunogenicity through activation of T follicular helper cells and germinal centre B cells","volume":"97","author":"Zhang","year":"2016","journal-title":"J Gen Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2022.08.059_b0445","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JVI.02904-14","article-title":"DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers","volume":"89","author":"Gupta","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0450","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-0716-1130-2_10","article-title":"Production of multi-subtype influenza Virus-Like Particles by molecular fusion with BAFF or APRIL for vaccine development","volume":"2248","author":"Chen","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2022.08.059_b0455","doi-asserted-by":"crossref","unstructured":"Vandenberk L, Belmans J, Van Woensel M, Riva M, Van Gool SW. Exploiting the immunogenic potential of cancer cells for improved dendritic cell vaccines. Front Immunol. 2016;6:663. doi: 10.3389\/fimmu.2015.00663.","DOI":"10.3389\/fimmu.2015.00663"},{"key":"10.1016\/j.vaccine.2022.08.059_b0460","doi-asserted-by":"crossref","unstructured":"Zhang H, Wang Y, Wang Q-T, Sun S-N, Li S-Y, Shang H, et al. Enhanced human T lymphocyte antigen priming by cytokine-matured dendritic cells overexpressing Bcl-2 and IL-12. Front Cell Dev Biol 2020;8:205. doi: 10.3389\/fcell.2020.00205.","DOI":"10.3389\/fcell.2020.00205"},{"issue":"17-18","key":"10.1016\/j.vaccine.2022.08.059_b0465","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0264-410X(02)00144-5","article-title":"Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectors","volume":"20","author":"Byrd","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.059_b0470","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1671-2927(09)60076-6","article-title":"Adjuvant effects of recombinant plasmids of Porcine IL-4 and IFN-\u03b3 to Cysticercosis cellulosae vaccines in mice and pigs","volume":"9","author":"Jing","year":"2010","journal-title":"Agri Sci China"},{"key":"10.1016\/j.vaccine.2022.08.059_b0475","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.vaccine.2011.02.035","article-title":"Development and immunogenicity of recombinant GapA+ Mycoplasma gallisepticum vaccine strain ts-11 expressing infectious bronchitis virus-S1 glycoprotein and chicken interleukin-6","volume":"29","author":"Shil","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2022.08.059_b0480","doi-asserted-by":"crossref","first-page":"e0141713","DOI":"10.1371\/journal.pone.0141713","article-title":"Mucosal immunogenicity of genetically modified Lactobacillus acidophilus expressing an HIV-1 epitope within the surface layer protein","volume":"10","author":"Kajikawa","year":"2015","journal-title":"PLoS ONE"},{"issue":"1-2","key":"10.1016\/j.vaccine.2022.08.059_b0485","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vetpar.2015.03.012","article-title":"Immunogenicity and protective efficacy of an Eimeria vaccine candidate based on Eimeria tenella immune mapped protein 1 and chicken CD40 ligand","volume":"210","author":"Yin","year":"2015","journal-title":"Vet Parasitol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22010490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22010490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:15:06Z","timestamp":1759403706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22010490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":97,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0264410X22010490"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of live vaccines by co-delivery of immune modulating proteins","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}